Efecto en la vida real sobre el control de los factores de riesgo asociado al inicio con polipíldora cardiovascular a partir de fármacos equipotentes / Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs

Objetivo: Analizar el impacto del inicio del tratamiento con la polipíldora-cardiovascular (CV) del Centro Nacional de Investigaciones Cardiovasculares (CNIC-Ferrer), en las cifras de presión arterial (PA) y colesterol ligado a lipoproteínas de baja densidad (LDL), de los pacientes de nuestra área sanitaria que previamente recibían dosis equipotentes de estatinas y antihipertensivos. Material y métodos: Se registraron todos los pacientes de nuestra área sanitaria (Santiago de Compostela) que a 31 de diciembre de 2019 tenían una prescripción activa de polipíldora-CV (CNIC-Ferrer), desde el 16 de enero de 2015. La fecha índice fue la fecha de inicio de prescripción de polipíldora-CV, y se analizaron los fármacos que previamente recibía el paciente para dislipemia e hipertensión arterial, clasificándose por equipotencias con atorvastatina y ramipril. Se analizó mediante la prueba t-Student para muestras apareadas las variaciones de colesterol LDL y PA. Resultados: Analizamos 547 pacientes con una edad media de 71,5±11,5 años y la mayoría varones (60,6%). Observamos un descenso del colesterol LDL (−10,6 [IC95%: −7,0, −14,3], p<0,001) en los pacientes (n=471) que iniciaron la polipíldora-CV con dosis previas equipotentes de atorvastatina. Documentamos una reducción de la PA sistólica (−3,7 [IC95%: −0,4, −6,9], p=0,029) en los pacientes (n=360) con inicio a partir de dosis equipotentes de ramipril. En 88 pacientes, el inicio de la polipíldora-CV se hizo a partir de dosis equipotentes de atorvastatina y ramipril observándose un descenso del colesterol LDL (−8,7 [IC95%: −3,8, −13,6], p=0,001) y de la PA sistólica (−3,6 [IC95%: −7,8, 0,5], p=0,085). Conclusiones: El inicio del tratamiento con la polipíldora-CV, en pacientes que previamente recibían tratamientos equipotentes de atorvastatina y ramipril, se asoció a una mayor reducción del colesterol LDL y la PA sistólica (AU)

Objective: This work aims to analyze the impact of Spain's National Center for Cardiovascular Research (CNIC-Ferrer)’s cardiovascular (CV)-polypill on blood pressure (BP) and low-density lipoprotein cholesterol (cLDL) levels in patients in our healthcare area who previously took equipotent doses of statins and antihypertensives. Material and methods: All patients in our healthcare area (Santiago de Compostela, Spain) who, as of December 31, 2019, had an active prescription for the CV-polypill (CNIC-Ferrer) since January 16, 2015 were registered. The index date was the start date of the CV-polypill prescription. The drugs the patient had previously received for dyslipidemia and hypertension were analyzed, classifying them by their equivalent potency to atorvastatin and ramipril. Changes in cLDL and BP were analyzed by means of Student's t-test for paired samples. Results: We analyzed 547 patients with a mean age of 71.5±11.5 years. The majority were men (60.6%). We observed a decrease in cLDL (−10.6 [95% CI: −7.0, −14.3], p<.001) in patients who started taking the CV-polypill who had previously taken equally potent doses of atorvastatin (n=471). We documented a reduction in systolic BP (−3.7 [95% CI: −0.4, −6.9], p=.029) in patients who had previously taken equally potent doses of ramipril (n=360). In 88 patients, the CV-polypill was started via equally potent doses of atorvastatin and ramipril, with a decrease in cLDL (−8.7 [95% CI: −3.8, −13.6], p=.001) and systolic BP (−3.6 [95% CI: −7.8, 0.5], p=.085). Conclusions: The initiation of treatment with the CV-polypill in patients who previously received equally potent treatment with atorvastatin and ramipril was associated with a greater reduction in cLDL and systolic BP (AU)

Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs.

OBJECTIVE: This work aims to analyze the impact of Spain's National Center for Cardiovascular Research (CNIC-Ferrer)'s cardiovascular (CV)-polypill on blood pressure (BP) and low-density lipoprotein cholesterol (cLDL) levels in patients in our healthcare area who previously took equipotent doses of statins and antihypertensives. MATERIAL AND METHODS: All patients in our healthcare area (Santiago de Compostela, Spain) who, as of December 31, 2019, had an active prescription for the CV-polypill (CNIC-Ferrer) since January 16, 2015 were registered. The index date was the start date of the CV-polypill prescription. The drugs the patient had previously received for dyslipidemia and hypertension were analyzed, classifying them by their equivalent potency to atorvastatin and ramipril. Changes in cLDL and BP were analyzed by means of Student's t-test for paired samples. RESULTS: We analyzed 547 patients with a mean age of 71.5 ± 11.5 years. The majority were men (60.6%). We observed a decrease in cLDL (-10.6 [95% CI: -7.0, -14.3], p < 0.001) in patients who started taking the CV-polypill who had previously taken equally potent doses of atorvastatin (n = 471). We documented a reduction in systolic BP (-3.7 [95% CI: -0.4, -6.9], p = 0.029) in patients who had previously taken equally potent doses of ramipril (n = 360). In 88 patients, the CV-polypill was started via equally potent doses of atorvastatin and ramipril, with a decrease in cLDL (-8.7 [95% CI: -3.8, -13.6], p = 0.001) and systolic BP (-3.6 [95% CI: -7.8, 0.5], p = 0.085). CONCLUSIONS: The initiation of treatment with the CV-polypill in patients who previously received equally potent treatment with atorvastatin and ramipril was associated with a greater reduction in cLDL and systolic BP.

Conocimiento y experiencia en violencia de género de las/os tutoras/es médicas/os y residentes de medicina de familia de Galicia / Knowledge and experience in gender violence of tutors and trainees of Galicia family medicine

OBJETIVO: Analizar el nivel de preparación, conocimiento y experiencia sobre la violencia de género de las/os tutoras/es médicas/os y las/os residentes de medicina de familia de las Unidades Docentes de Atención Familiar y Comunitaria de Galicia. MÉTODO: Estudio descriptivo transversal en las siete Unidades Docentes de Atención Familiar y Comunitaria de Galicia. Se utilizó el cuestionario Physician Readiness Manage Intimate Violence Survey (PREMIS), en su versión validada en español. Esta encuesta permite recoger información de las/os profesionales sanitarios de atención primaria sobre sus actitudes, conocimientos y prácticas con respecto a la violencia de género. Se realizó análisis estadístico descriptivo y comparativo de los datos. RESULTADOS: Se recibieron 159 cuestionarios, 72,32% procedían de mujeres, 59,1% de las respuestas fueron de médicas/os tutoras/es. Se apreció que existían diferencias estadísticamente significativas en la detección/diagnóstico de violencia a favor que aquellas/os profesionales que tenían conocimiento del protocolo de violencia de género o que habían recibido formación sobre esta materia (p < 0,01). En la autopercepción de la formación sobre violencia de género se observaron peores resultados con significación estadística en aquellas/os profesionales con mayor carga asistencial (p < 0,05). CONCLUSIONES: Haber recibido formación o conocer el protocolo de atención sanitaria se asocia con una mayor detección de casos de violencia de género. Se ha constatado déficit en formación en violencia de género tanto en tutoras/es como en residentes de medicina de familia, especialmente en los que tienen mayor carga asistencial, por lo que es una prioridad desarrollar estrategias de formación médica en este campo

OBJECTIVE: To analyse the level of preparation, knowledge and experience of gender violence of medical tutors and family medicine trainees of the Teaching Units of Family and Community Care of Galicia. METHODS: Descriptive cross-sectional study conducted in the 7 Teaching Units of Family and Community Care in Galicia. The Physician Readiness Manage Intimate Violence Survey (PREMIS), in its validated version in Spanish was used. This survey allows the collection of information from primary health care professionals about their attitudes, knowledge, and practices as regards gender violence. A descriptive and comparative statistical analysis was performed on the data. RESULTS: Out of a total of 159 questionnaires received, 72.32% came from women, and 59.1% of the responses were from doctors / tutors. It was noted that there were statistically significant differences in the detection / diagnosis of violence by those professionals who were aware of the gender violence protocol or who had received training in this area (P<.01). In the self-perception of gender violence training, statistically significant worse results were observed in those professionals with greater care burden (P<.05). CONCLUSIONS: Having received training or knowing the health care protocol on gender violence is associated with greater detection of cases of gender violence. There has been a deficit in training in gender-based violence both in tutors and in family medicine residents, especially in those with greater care burden, so it is a priority to develop medical training strategies in this field

Residentes de familia en estado de alarma / General practitioners residents at emergency state

No disponible

[Knowledge And Experience In Gender Violence Of Tutors And Trainees Of Galicia Family Medicine]. / Conocimiento y experiencia en violencia de género de las/os tutoras/es médicas/os y residentes de medicina de familia de Galicia.

OBJECTIVE: To analyse the level of preparation, knowledge and experience of gender violence of medical tutors and family medicine trainees of the Teaching Units of Family and Community Care of Galicia. METHODS: Descriptive cross-sectional study conducted in the 7 Teaching Units of Family and Community Care in Galicia. The Physician Readiness Manage Intimate Violence Survey (PREMIS), in its validated version in Spanish was used. This survey allows the collection of information from primary health care professionals about their attitudes, knowledge, and practices as regards gender violence. A descriptive and comparative statistical analysis was performed on the data. RESULTS: Out of a total of 159 questionnaires received, 72.32% came from women, and 59.1% of the responses were from doctors / tutors. It was noted that there were statistically significant differences in the detection / diagnosis of violence by those professionals who were aware of the gender violence protocol or who had received training in this area (P<.01). In the self-perception of gender violence training, statistically significant worse results were observed in those professionals with greater care burden (P<.05). CONCLUSIONS: Having received training or knowing the health care protocol on gender violence is associated with greater detection of cases of gender violence. There has been a deficit in training in gender-based violence both in tutors and in family medicine residents, especially in those with greater care burden, so it is a priority to develop medical training strategies in this field.